Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global RNAi Technologies Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global RNAi Technologies Market Status and Forecast (2016-2027)
      • 1.3.2 Global RNAi Technologies Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global RNAi Technologies Supply by Company

    • 2.1 Global RNAi Technologies Sales Value by Company
    • 2.2 RNAi Technologies Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional RNAi Technologies Market Status by Category

    • 3.1 RNAi Technologies Category Introduction
      • 3.1.1 Oncology
      • 3.1.2 Ocular Disorders
      • 3.1.3 Respiratory Disorders
      • 3.1.4 Liver Diseases
      • 3.1.5 Other
    • 3.2 Global RNAi Technologies Market by Category
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional RNAi Technologies Market Status by End User/Segment

    • 4.1 RNAi Technologies Segment by End User/Segment
      • 4.1.1 Research
      • 4.1.2 Therapeutics
    • 4.2 Global RNAi Technologies Market by End User/Segment
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global RNAi Technologies Market Status by Region

    • 5.1 Global RNAi Technologies Market by Region
    • 5.2 North America RNAi Technologies Market Status
    • 5.3 Europe RNAi Technologies Market Status
    • 5.4 Asia Pacific RNAi Technologies Market Status
    • 5.5 Central & South America RNAi Technologies Market Status
    • 5.6 Middle East & Africa RNAi Technologies Market Status

    6 North America RNAi Technologies Market Status

    • 6.1 North America RNAi Technologies Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe RNAi Technologies Market Status

    • 7.1 Europe RNAi Technologies Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific RNAi Technologies Market Status

    • 8.1 Asia Pacific RNAi Technologies Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America RNAi Technologies Market Status

    • 9.1 Central & South America RNAi Technologies Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa RNAi Technologies Market Status

    • 10.1 Middle East & Africa RNAi Technologies Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global RNAi Technologies Market Forecast by Category and by End User/Segment

    • 12.1 Global RNAi Technologies Sales Value Forecast (2022-2027)
    • 12.2 Global RNAi Technologies Forecast by Category
    • 12.3 Global RNAi Technologies Forecast by End User/Segment

    13 Global RNAi Technologies Market Forecast by Region/Country

    • 13.1 Global RNAi Technologies Market Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 RXI Pharmaceuticals
      • 14.1.1 Company Information
      • 14.1.2 RNAi Technologies Product Introduction
      • 14.1.3 RXI Pharmaceuticals RNAi Technologies Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Quark Pharmaceuticals Inc.
      • 14.2.1 Company Information
      • 14.2.2 RNAi Technologies Product Introduction
      • 14.2.3 Quark Pharmaceuticals Inc. RNAi Technologies Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Qiagen
      • 14.3.1 Company Information
      • 14.3.2 RNAi Technologies Product Introduction
      • 14.3.3 Qiagen RNAi Technologies Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Ionis Pharmaceuticals
      • 14.4.1 Company Information
      • 14.4.2 RNAi Technologies Product Introduction
      • 14.4.3 Ionis Pharmaceuticals RNAi Technologies Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Invitrogen
      • 14.5.1 Company Information
      • 14.5.2 RNAi Technologies Product Introduction
      • 14.5.3 Invitrogen RNAi Technologies Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Filmtec Corporation
      • 14.6.1 Company Information
      • 14.6.2 RNAi Technologies Product Introduction
      • 14.6.3 Filmtec Corporation RNAi Technologies Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Benitec Biopharma Ltd
      • 14.7.1 Company Information
      • 14.7.2 RNAi Technologies Product Introduction
      • 14.7.3 Benitec Biopharma Ltd RNAi Technologies Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Ambion
      • 14.8.1 Company Information
      • 14.8.2 RNAi Technologies Product Introduction
      • 14.8.3 Ambion RNAi Technologies Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Alnylam Pharmaceuticals
      • 14.9.1 Company Information
      • 14.9.2 RNAi Technologies Product Introduction
      • 14.9.3 Alnylam Pharmaceuticals RNAi Technologies Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.9.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global RNAi Technologies market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global RNAi Technologies market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Oncology
      Ocular Disorders
      Respiratory Disorders
      Liver Diseases
      Other

      Segmented by End User/Segment
      Research
      Therapeutics

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      RXI Pharmaceuticals
      Quark Pharmaceuticals Inc.
      Qiagen
      Ionis Pharmaceuticals
      Invitrogen
      Filmtec Corporation
      Benitec Biopharma Ltd
      Ambion
      Alnylam Pharmaceuticals
      Buy now